Pfizer Inc (PFE)

PFE on New York Consolidated

29.37USD
29 Aug 2014
Price Change (% chg)

$-0.01 (-0.05%)
Prev Close
$29.38
Open
--
Day's High
--
Day's Low
--
Volume
8,430,677
Avg. Vol
23,071,300
52-wk High
$32.96
52-wk Low
$27.86

PFE

Chart for PFE

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.68
Market Cap (Mil.): $186,358.00
Shares Outstanding (Mil.): 6,340.86
Dividend: 0.26
Yield (%): 3.54

Financials

  PFE Industry Sector
P/E (TTM): 18.54 32.30 33.23
EPS (TTM): 1.59 -- --
ROI: 6.80 17.96 17.21
ROE: 13.38 18.60 18.01
Search Stocks

Early data suggest Sanofi, Regeneron drug may halve heart risk

* Good news for new PCSK9 drug class but needs confirmation

31 Aug 2014

FTSE inches higher, Tesco slumps after profit warning

LONDON, Aug 29 - Britain's top share index ended slightly higher on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks outpacing a sharp decline in retail stocks after another profit warning by Tesco .

29 Aug 2014

Germany's Bayer to launch three new Xarelto trials

FRANKFURT - Germany's Bayer unveiled plans to launch three new studies to expand the uses of its anti-clotting drug Xarelto, one of its top five new medicines.

29 Aug 2014

FTSE steadies, Tesco slumps after profit warning

LONDON, Aug 29 - Britain's top share index steadied in cautious trading on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks offsetting weaker retailers after another profit warning by Tesco.

29 Aug 2014

FTSE edges higher, stronger drugmakers outpace weak retailers

LONDON, Aug 29 - Britain's top share index edged higher in cautious trading on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks outpacing weaker retailers after another profit warning by Tesco .

29 Aug 2014

UPDATE 1-AstraZeneca boosted by start of new cancer drug trial

* AstraZeneca shares up 2 percent (Adds sales forecasts, detail on competitors, latest shares)

29 Aug 2014

Britain's FTSE creeps higher; Tesco slides on profit warning

LONDON, Aug 29 - British shares inched higher on Friday in cautious trade as investors awaited inflation figures for the euro zone which may shed light on the European Central Bank's next move, though shares in Tesco dropped sharply on the back of a profit warning.

29 Aug 2014

Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

26 Aug 2014

RPT-UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

Aug 26 - Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

26 Aug 2014

UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

Aug 26 - Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

26 Aug 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $103.73 +0.78
Novartis AG (NOVN.VX) CHF85.90 +3.55
Merck & Co., Inc. (MRK.N) $60.11 +0.11
Roche Holding Ltd. (ROG.VX) CHF269.30 +1.60
Abbott Laboratories (ABT.N) $42.24 -0.11
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €83.54 +0.04
AstraZeneca plc (AZN.L) 4,577.50p +10.50
GlaxoSmithKline plc (GSK.L) 1,460.00p -14.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks